Skip to main content

CLC Bio Lands $1.3M for European Omics Data Effort

NEW YORK (GenomeWeb News) – Danish bioinformatics firm CLC Bio said today that it will receive $1.3 million for its participation in a $7.8 million European Commission-funded project that seeks to develop a user-friendly analysis platform for omics data.

CLC Bio said it will support the multinational STATegra project, an effort to create new statistical methods for analyzing a wide range of omics datasets, by making these new methods available through its software packages and by enhancing them with its visualization toolkit.

The STATegra partners plan to make these new methods and tools available rapidly for use in analyzing data from studies using mRNA-seq, miRNA-seq, methyl-seq, chip-seq, DNase-seq, proteomics, and metabolomics approaches. The experimental results from STATegra's analyses efforts will be returned back to the public domain.

"One of the big challenges today is going past the raw sequence data and getting to grips with the complexity of epigenetic processes," CLC Bio Senior Bioinformatics Scientist Michael Lappe said in a statement.

Lappe added that the company will work with STATegra partners to make "this extremely complex network biology understandable. Ultimately our tools will facilitate the translation of massive amounts of data into useful insights that can be applied in clinical settings."

Along with CLC Bio, STATegra partners include Biomax Informatics; the Karolinska Institute; Imperial College of Science, Technology, and Medicine; Greece's Foundation for Research and Technology; Spain's Bellvitge Biomedical Research Institute; the University of Amsterdam; the University of Leiden; the Ludwig-Maximilians University of Munich; and the University of California.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.